Lightweight 3D CNN for MRI Analysis in Alzheimer's Disease: Balancing Accuracy and Efficiency

用于阿尔茨海默病MRI分析的轻量级3D CNN:平衡准确性和效率

阅读:1

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by subtle structural changes in the brain, which can be observed through MRI scans. Although traditional diagnostic approaches rely on clinical and neuropsychological assessments, deep learning-based methods such as 3D convolutional neural networks (CNNs) have recently been introduced to improve diagnostic accuracy. However, their high computational complexity remains a challenge. To address this, we propose a lightweight magnetic resonance imaging (MRI) classification framework that integrates adaptive multi-scale feature extraction with structural pruning and parameter optimization. The pruned model achieving a compact architecture with approximately 490k parameters (0.49 million), 4.39 billion floating-point operations, and a model size of 1.9 MB, while maintaining high classification performance across three binary tasks. The proposed framework was evaluated on the Alzheimer's Disease Neuroimaging Initiative dataset, a widely used benchmark for AD research. Notably, the model achieves a performance density(PD) of 189.87, where PD is a custom efficiency metric defined as the classification accuracy per million parameters (% pm), which is approximately 70× higher than the basemodel, reflecting its balance between accuracy and computational efficiency. Experimental results demonstrate that the proposed framework significantly reduces resource consumption without compromising diagnostic performance, providing a practical foundation for real-time and resource-constrained clinical applications in Alzheimer's disease detection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。